In 1989, a new type of antibody was identified, first in the sera of dromedaries and later also
in all other species of the Camelidae family. These antibodies do not contain a light chain …

Summary Background Treatment of HBeAg-positive patients with chronic hepatitis B is not
effective in most. A combination of immunomodulatory pegylated interferon alfa-2b and …

Chronic infection with the hepatitis B virus remains a serious and life-threatening disease for
approximately 5% of the world's population, despite the availability of effective vaccines …

Background: Conventional interferon and lamivudine monotherapy are unsatisfactory in
treating hepatitis B virus (HBV) infection. Objective: To evaluate the efficacy and safety of …

MicroRNAs are small non-coding RNAs that modulate gene expression at post-
transcriptional level, playing a crucial role in cell differentiation and development. Recently …

Background: Adefovir dipivoxil (ADV) is a potent nucleotide analogue against both the wild-
type and lamivudine (LMV) resistant hepatitis B virus (HBV). The cumulative incidence of …

Page 1 ВФУчайкин ТВЧередниченко АВСмирнов ИНФЕКЦИОННАЯ ГЕПАТОЛОГИЯ
РУКОВОДСТВО ДЛЯ ВРАЧЕЙ ИЗДАТЕЛЬСКАЯ ГРУППА «ГЭОТАР-Медиа» Page 2 ВФУчайкин …

In our continuing study of biologically active compounds from Korean medicinal plants, we
investigated the hepatoprotective constituents of the aerial parts of Lactuca indica …

Background and aim Viral load is used for the diagnosis and monitoring the treatment of
chronic hepatitis B (CHB). These methods are molecular-based and are expensive …

Conventional interferon alfa and nucleos (t) ide analogues, such as lamivudine, are
frequently used for chronic hepatitis B (CHB) treatment, but are associated with adverse …